The artificial intelligence (AI) has a lot of help for the health care industry. The two AI systems published in the UK recently have better accuracy and efficiency in diagnosing heart disease and lung cancer than human experts. It is expected to be diagnosed earlier in the future. Related diseases, saving lives, and saving the British National Health Service (NHS) billions of pounds of spending, so that limited medical resources can be more effective.
It has been reported that human physicians are unable to correctly diagnose heart disease and lung cancer 100%. Misdiagnosis may result in delays in treatment or unnecessary medical treatment, while failure to diagnose may lead to additional testing and waiting anxiety. The newly developed AI diagnostic system delivers more accurate and rapid performance than human physicians, providing excellent diagnostic support.
It is not only a powerful tool to help humans improve their work and efficiency, but also to save costs for medical institutions. Since the diagnosis is only one of the various tasks that the physician must be able to handle, there is no concern that it will be replaced by AI for at least a short period of time.
At present, cardiologists use a scan to assess the patient's heartbeat time to determine if the heart is normal. According to the BBC News report, in the 60,000 heart scans performed by the NHS, the correct diagnosis of cardiologists is 80%, but 12,000 cases are misdiagnosed. Some are judged to have normal heart but are at home, and those who have been mistakenly sentenced to have heart disease suffer from unnecessary surgery and treatment. It is estimated that the NHS is wasted 600 million pounds.
A team of researchers at the John Radcliffe Hospital in Oxford, UK, developed the AI ​​system Ultrasics, using the heart scan data of 1,000 patients treated by Paul Leeson, the medical director of the hospital over the past seven years, and whether or not to determine information about heart disease. Ultromics, the result of diagnosis of heart disease is more accurate than human physicians.
After several clinical trials in six cardiology units, Ultramics can identify the details ignored by physicians and assess the risk of heart disease and provide clinical advice when analyzing scan data, significantly surpassing the performance of human cardiologists. The specific results are expected to be published in the journal in 2018. From the summer of 2018, Ultramics will be available free of charge to NHS hospitals, saving more than £300 million annually for NHS.
The human physician cannot confirm that the nodules found in the lung scan data are harmless or carcinogenic, and the patient must perform multiple scans to observe the subsequent development of the nodules. The AI ​​system developed by the startup Optellum can analyze scan data to find nodules to diagnose lung cancer. Various clinical trials have shown that this system can eliminate harmless nodules, and early diagnosis allows patients to avoid subsequent scans and torments.
In addition, the system can provide very early warning of lung cancer, which is much more efficient than human physicians. Therefore, the medical resources saved can be transferred to the early screening of lung cancer, allowing more than 4,000 lung cancer patients to be taken earlier every year. Diagnosed, it is possible to get a greater chance of survival, and the NHS spending is greatly reduced.
Optellum is currently commercializing the system, and if both the US and the European Union decide to use Optellum's AI lung cancer diagnostic system, it is estimated to save £10 billion.
John Bell, a professor at the University of Oxford Medical School in the United Kingdom, pointed out that the AI ​​diagnostic system will have a very positive impact on the financial rescue of the NHS. The NHS has a chance to reduce the pathological service expenditure of about 2.2 billion pounds by 50%. The savings in medical costs will also be used to hire more physicians, caregivers, hospital staff and purchase new instruments to improve the quality of care.
In addition, the more positive significance of the UK's benefit from AI is that organizations with limited resources such as NHS can provide better health care to more people with the same GDP ratio.
Air Bar Box Disposable Vape uses a 14ml vape juice capacity to provide up to 5000 puffs in each vape. Designed by leading vape manufacturer, Suorin, this rechargeable vape also utilizes a premium mesh coil for quality flavor in every Air Bar Box. Shop a wide variety of Air Bar Box flavors including everything from Rainbow Blast to Jungle Juice today at Mi-Pod.
Air Bar Box,E-Cigarette Pen,E-Cigarette Vape Pen, Disposable Vape Pen Puff
Nanning Goodman Technology Co.,Ltd , https://www.goodmentech.com